Clinical role of positron emission tomography in oncology-Reference-Cited by-同舟云学术

Clinical role of positron emission tomography in oncology

Published:2001-03 Issue:3 Volume:2 Page:157-164
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bomanji JB,Costa DC,Ell PJ

Publisher

Elsevier BV

Subject

Oncology

Reference47 articles.

1. How cells absorb glucose;Lienhard;Sci Am,1992

2. Metabolic staging of lung cancer;Berlangieri;N Engl 3. Med,2000

3. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s – meta-analytic comparison of PET and CT;Dwamena;Radiology,1999

4. Preoperative staging of non-small-cell lung cancer with positron-emission tomography;Pieterman;N Engl J Med,2000

5. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small cell lung carcinoma;Gambhir;J Nucl Med,1996

Cited by 231 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer;Non-coding RNA Research;2024-03

2. Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans;Phytochemistry;2024-02

3. Common anesthetic used in preclinical PET imaging inhibits metabolism of the PET tracer [¹⁸F]3F4AP;2023-12-14

4. Dose reduction in dynamic synaptic vesicle glycoprotein 2A PET imaging using artificial neural networks;Physics in Medicine & Biology;2023-12-08

5. HER2 low expression breast cancer subtyping and their correlation with prognosis and immune landscape based on the histone modification related genes;Scientific Reports;2023-12-08